Terumo (OTCMKTS:TRUMY) Shares Gap Down – Here’s Why

Posted by Brian Himes on Oct 2nd, 2026

Shares of Terumo Corp. (OTCMKTS:TRUMY – Get Free Report) gapped down before the market opened on Friday. The stock had previously closed at $14.72, but opened at $14.21. Terumo shares last traded at $14.2427, with a volume of 1,217 shares.

Analyst Ratings Changes

Separately, Nomura upgraded shares of Terumo from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy”.

View Our Latest Report on Terumo

Terumo Price Performance

The business’s 50 day moving average is $15.13 and its two-hundred day moving average is $14.15. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.19 and a quick ratio of 1.37. The firm has a market capitalization of $20.96 billion, a PE ratio of 20.01 and a beta of 0.77.

Terumo (OTCMKTS:TRUMY – Get Free Report) last announced its quarterly earnings data on Friday, August 7th. The company reported $0.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.13. Terumo had a net margin of 13.83% and a return on equity of 10.44%. The business had revenue of $1.97 billion during the quarter, compared to analyst estimates of $1.84 billion. As a group, research analysts anticipate that Terumo Corp. will post 0.86 EPS for the current year.

Terumo Company Profile

(Get Free Report)

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other healthcare settings. Founded in 1921 by a group of Japanese medical doctors, the company initially produced clinical thermometers and has since expanded into a global provider of medical devices and related services.

Terumo’s principal businesses include cardiac and vascular products, blood and cell technologies, and general hospital solutions.